Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Astrocytoma × Diffusion Tensor Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 4 Breast Neoplasms 4 Brain Neoplasms 4 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Vision Disorders 1 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pituitary Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuritis 1 Neoplasm Metastasis 1 Medulloblastoma 1 Mediastinal Neoplasms 1 Lymphedema 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Familial ependymoma 1 Esthesioneuroblastoma, Olfactory 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 107 Radiotherapy 59 Carboplatin 28 Bevacizumab 28 Carmustine 26 Magnetic Resonance Spectroscopy 24 Filgrastim 20 Surgical Procedures, Operative 18 Irinotecan 18 Radiation 16 Lomustine 16 Vincristine 14 Etoposide 13 Specimen Handling 11 Radiotherapy, Intensity-Modulated 11 Procarbazine 11 Peripheral Blood Stem Cell Transplantation 11 O(6)-benzylguanine 11 Erlotinib Hydrochloride 11 Cyclophosphamide 11 sargramostim 10 Chemotherapy, Adjuvant 10 Cisplatin 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Thiotepa 8 Granulocyte Colony-Stimulating Factor 8 Flucytosine 8 Everolimus 7 vocimagene amiretrorepvec 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡